Blackstone Clarus GP L.P.'s Net Worth

$2.21 Million

Estimate Recalculated Jun 27, 2024 07:14AM EST

Who is Blackstone Clarus GP L.P.?

Blackstone Clarus GP L.P. has an estimated net worth of $2.21 Million. This is based on reported shares across multiple companies, which include Talaris Therapeutics, Inc., and Galera Therapeutics, Inc..

SEC CIK

Blackstone Clarus GP L.P.'s CIK is 0001793311

Past Insider Trading and Trends

2021 was Blackstone Clarus GP L.P.'s most active year for acquiring shares with 20 total transactions. Blackstone Clarus GP L.P.'s most active month to acquire stocks was the month of April. 2021 was Blackstone Clarus GP L.P.'s most active year for disposing of shares, totalling 13 transactions. Blackstone Clarus GP L.P.'s most active month to dispose stocks was the month of April. 2019 saw Blackstone Clarus GP L.P. paying a total of $3,000,000.00 for 1,678,984 shares, this is the most they've acquired in one year. In 2021 Blackstone Clarus GP L.P. cashed out on 43,117,391 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Talaris Therapeutics, Inc. (TRML) Snapshot price: $35.6

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+75.24%
8.09M
$17.00
$510,000.00
18.84M
May 11
Form 3
—
0
—
—
0
No matching records found

Galera Therapeutics, Inc. (GRTX) Snapshot price: $0.1729

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+117.49%
1.68M
$12.00
$3,000,000.00
3.11M
Nov 12
Form 3
—
0
—
—
0
No matching records found